These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7114073)

  • 1. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
    Saito H; Goodnough LT; Boyle JM; Heimburger N
    Am J Med; 1982 Aug; 73(2):179-82. PubMed ID: 7114073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.
    Leebeek FW; Kluft C; Knot EA; De Maat MP
    J Lab Clin Med; 1989 Apr; 113(4):493-7. PubMed ID: 2703760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-rich glycoprotein and changes in the components of the fibrinolytic system after streptokinase therapy in patients with pulmonary thromboembolism.
    Goodnough LT; Saito H; Bell WR; Heimburger N
    Am J Hematol; 1985 Jul; 19(3):245-53. PubMed ID: 4014225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of diffuse intravascular coagulation and fibrinolysis in patients with liver cirrhosis.
    van Wersch JW; Russel MG; Lustermans FA
    Eur J Clin Chem Clin Biochem; 1992 May; 30(5):275-9. PubMed ID: 1627724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinolytic system in the newborn: role of histidine-rich glycoprotein.
    Caccamo ML; Rossi E; Salmoiraghi MG; Mondonico P; Gianotti GA; Marini A
    Biol Neonate; 1992; 61(5):281-4. PubMed ID: 1391253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.
    Lijnen HR; Hoylaerts M; Collen D
    J Biol Chem; 1980 Nov; 255(21):10214-22. PubMed ID: 6448849
    [No Abstract]   [Full Text] [Related]  

  • 8. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.
    Kluft C; Los P
    Thromb Haemost; 1988 Dec; 60(3):411-4. PubMed ID: 2467400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis.
    Marongiu F; Mamusa AM; Mameli G; Mulas G; Solinas A; Demelia L; Contu L
    Thromb Res; 1985 Jan; 37(2):287-94. PubMed ID: 3975873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
    Ichinose A; Mimuro J; Koide T; Aoki N
    Thromb Res; 1984 Feb; 33(4):401-7. PubMed ID: 6710439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma histidine-rich glycoprotein and plasminogen in patients with liver disease.
    Gram J; Jespersen J; Ingeberg S; Bentsen KD; Bach E
    Thromb Res; 1985 Aug; 39(4):411-7. PubMed ID: 4049324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro.
    Horne MK; Goad JL; Merryman PK; Cullinane AM
    Thromb Res; 2000 Jul; 99(2):179-86. PubMed ID: 10946092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fibrinolysis and protein C increase after cadaver kidney transplantation.
    Seitz R; Michalik R; Karges HE; Lange H; Egbring R
    Thromb Res; 1986 May; 42(3):277-88. PubMed ID: 2424120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor.
    Hersch SL; Kunelis T; Francis RB
    Blood; 1987 May; 69(5):1315-9. PubMed ID: 2436684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
    Cordova C; Musca A; Violi F; Alessandri C; Ferro D; Piromalli A; Balsano F
    Haemostasis; 1984; 14(2):218-22. PubMed ID: 6564063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.